Product Development and Regulatory Affairs

The Product Development and Regulatory Affairs team at Oncolytics Biotech is responsible for guiding the development of REOLYSIN® through its various stages, from pre-clinical to clinical trials. This team ensures that all products meet regulatory standards and quality requirements, while also overseeing drug safety and compliance with industry regulations. They collaborate closely with research, quality assurance, and translational science teams to facilitate the timely and successful advancement of innovative cancer therapies.